(NASDAQ: FEMY) Femasys's forecast annual revenue growth rate of 195.99% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Femasys's revenue in 2025 is $1,699,232.On average, 2 Wall Street analysts forecast FEMY's revenue for 2025 to be $186,593,212, with the lowest FEMY revenue forecast at $144,371,391, and the highest FEMY revenue forecast at $228,815,034. On average, 1 Wall Street analysts forecast FEMY's revenue for 2026 to be $452,182,091, with the lowest FEMY revenue forecast at $452,182,091, and the highest FEMY revenue forecast at $452,182,091.
In 2027, FEMY is forecast to generate $1,307,514,480 in revenue, with the lowest revenue forecast at $1,307,514,480 and the highest revenue forecast at $1,307,514,480.